These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3318028)

  • 21. [Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].
    Kupferschmidt HG; Schröder K; Beltzner B
    Angew Parasitol; 1988 Nov; 29(4):211-3. PubMed ID: 3072886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fansidar resistant falciparum malaria acquired in South East Asia.
    Black F; Bygbjerg I; Effersøe P; Gomme G; Jepsen S; Jensen GA
    Trans R Soc Trop Med Hyg; 1981; 75(5):715-6. PubMed ID: 7036431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent chloroquine- and Fansidar-resistant Plasmodium falciparum: an imported case into Zimbabwe.
    Dallas AB; Okwanga PN; Mutambu SL; Pfumojena JW
    J Trop Med Hyg; 1986 Oct; 89(5):265-8. PubMed ID: 3540319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Sabah, Malaysia.
    Tan HS; Tan PE
    Ann Acad Med Singap; 1984 Apr; 13(2):170-4. PubMed ID: 6388486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible sulfadoxine-pyrimethamine resistance in Plasmodium falciparum malaria from Kenya.
    Markwalder KA; Meyer HE
    Trans R Soc Trop Med Hyg; 1982; 76(2):281. PubMed ID: 7048656
    [No Abstract]   [Full Text] [Related]  

  • 26. Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine/sulfadoxine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 May; 38(20):363-4. PubMed ID: 2497333
    [No Abstract]   [Full Text] [Related]  

  • 27. The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria.
    Olatunde A; Salako LA; Walker O
    Trans R Soc Trop Med Hyg; 1981; 75(6):848-50. PubMed ID: 7036438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):21-22, 27. PubMed ID: 3001495
    [No Abstract]   [Full Text] [Related]  

  • 29. RI quinine-Fansidar resistant falciparum malaria from Malawi.
    Warhurst DC; Hall AP; Tjokrosonto S
    Lancet; 1985 Aug; 2(8450):330. PubMed ID: 2862492
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.
    Hess U; Timmermans PM; Jones M
    Am J Trop Med Hyg; 1983 Mar; 32(2):217-20. PubMed ID: 6340538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected.
    Kilimali VA; Mkufya AR
    Trans R Soc Trop Med Hyg; 1985; 79(4):482-3. PubMed ID: 3909553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Falciparum malaria resistant to chloroquine and Fansidar.
    Jaatinen M; Kihamia CM; McLarty DG
    Br Med J (Clin Res Ed); 1984 Jan; 288(6410):65. PubMed ID: 6418318
    [No Abstract]   [Full Text] [Related]  

  • 33. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
    Schapira A; Bygbjerg IC; Jepsen S; Flachs H; Bentzon MW
    Am J Trop Med Hyg; 1986 Mar; 35(2):239-45. PubMed ID: 3513641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leads from the MMWR. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
    JAMA; 1986 Feb; 255(5):597. PubMed ID: 3003409
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effectiveness of treatment with chloroquine, fansidar and dabequin of Plasmodium falciparum carriers, residing in a hyperendemic focus of malaria (the city of Bagamoyo, Northeastern Tanzania)].
    Kuznetsov RL; Kilama V; Peĭn D; Kampbell SS; Stori D
    Med Parazitol (Mosk); 1985; (4):15-9. PubMed ID: 3903459
    [No Abstract]   [Full Text] [Related]  

  • 36. A case of Plasmodium falciparum infection resistant to chloroquine.
    Assefa T
    Ethiop Med J; 1987 Oct; 25(4):209-10. PubMed ID: 3311731
    [No Abstract]   [Full Text] [Related]  

  • 37. Falciparum malaria resistant to chloroquine and Fansidar: implications for prophylaxis.
    Eyre SJ
    Br Med J (Clin Res Ed); 1984 Feb; 288(6417):644. PubMed ID: 6421416
    [No Abstract]   [Full Text] [Related]  

  • 38. The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children.
    Ogutu BR; Smoak BL; Nduati RW; Mbori-Ngacha DA; Mwathe F; Shanks GD
    Trans R Soc Trop Med Hyg; 2000; 94(1):83-4. PubMed ID: 10748907
    [No Abstract]   [Full Text] [Related]  

  • 39. [Unsuccessful effect of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Tanzania].
    Vestergaard Olsen V
    Ugeskr Laeger; 1983 Mar; 145(10):751. PubMed ID: 6344376
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trial of fansimef in Indian patients of P. falciparum malaria.
    Asthana OP; Tangri AN; Nityanand S
    Indian J Malariol; 1988 Dec; 25(2):89-96. PubMed ID: 3077373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.